The recruitment mechanisms and potential therapeutic targets of podocytes from parietal epithelial cells

J Transl Med. 2021 Oct 21;19(1):441. doi: 10.1186/s12967-021-03101-z.

Abstract

Podocytes are differentiated postmitotic cells which cannot be replaced after podocyte injury. The mechanism of podocyte repopulation after injury has aroused wide concern. Parietal epithelial cells (PECs) are heterogeneous and only a specific subpopulation of PECs has the capacity to replace podocytes. Major progress has been achieved in recent years regarding the role and function of a subset of PECs which could transdifferentiate toward podocytes. Additionally, several factors, such as Notch, Wnt/ß-catenin, Wilms' tumor-1, miR-193a and growth arrest-specific protein 1, have been shown to be involved in these processes. Finally, PECs serve as a potential therapeutic target in the conditions of podocyte loss. In this review, we discuss the latest observations and concepts about the recruitment of podocytes from PECs in glomerular diseases as well as newly identified mechanisms and the most recent treatments for this process.

Keywords: Parietal epithelial cells; Podocyte; Progenitors; Recruitment; Transdifferentiate.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bowman Capsule
  • Epithelial Cells
  • Humans
  • Kidney Diseases*
  • Podocytes*